CVKD - Cadrenal Therapeutics, Inc.
8.28
0.285 3.442%
Share volume: 16,091
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$8.00
0.28
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-07-2024 | 11-07-2024 | 03-13-2025 | 05-08-2025 | 11-10-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 1.755 M | 2.466 M | 2.460 M | 4.278 M | 3.922 M | 2.733 M | |
| Selling general and admin | 1.126 M | 1.212 M | 1.675 M | 2.740 M | 2.255 M | 2.045 M | |
| Research and development | 629.025 K | 1.254 M | 784.646 K | 1.538 M | 1.668 M | 688.465 K | |
| Total expenses | 1.756 M | 2.467 M | 2.460 M | 4.278 M | 3.928 M | 2.734 M | |
| 40.50% | -0.27% | 73.92% | -8.19% | -30.40% | |||
| Operating income | -1.756 M | -2.467 M | -2.460 M | -4.278 M | -3.928 M | -2.734 M | |
| Ebit | -1.756 M | -2.467 M | -2.460 M | -4.278 M | -3.928 M | -2.734 M | |
| Pretax income | -1.663 M | -2.393 M | -2.408 M | -4.187 M | -3.845 M | -2.686 M | |
| 43.87% | 0.62% | 73.90% | -8.16% | -30.16% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -1.663 M | -2.393 M | -2.408 M | -4.187 M | -3.845 M | -2.686 M | |
| -43.87% | -0.62% | -73.90% | 8.16% | 30.16% |